BIOPERSIST

medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders

clinical trials; conducting interventional clinical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the fields of clinical trials and post-market trials; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineering